Premier Member - Rayner Intraocular Lenses

The only manufacturer of intraocular lenses in the UK

Rayner is leading the way in ophthalmic innovation with IOLs and ophthalmic solutions designed to provide surgeons and patients with the best visual outcomes.

When ophthalmologist Sir Harold Ridley implanted the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention. Since then, Rayner has experienced over 75 years of continuous growth and experience, now selling in over 95 countries worldwide.

Our mission is to deliver innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in us to improve sight and quality of life.

Rayner has a broad portfolio of products across the patient pathway, including monofocal and premium Intraocular Lenses (IOLs), a full range of Ophthalmic Viscosurgical Devices (OVDs), a family of Ocular Surface Disease (OSD) solutions, SOPHI Phaco emulsification machine, and RayPRO, the only digital patient outcomes platform specifically designed for ophthalmology.

With regional offices in every corner of the world, Rayner’s state-of-the-art global headquarters and manufacturing plant are in Worthing on the South Coast of the UK.

Rayner is a British company and the only manufacturer of intraocular lenses in the UK.

Our dedicated Research & Development team are committed to their mission of developing innovative new products, clinically superior materials and state-of-the-art automated manufacturing equipment.

Combining extensive in-house technical expertise in the fields of advanced optics, materials, injector design and automation, together with a collaborative cross-departmental project management culture, enables us to position ourselves at the forefront of the IOL market with a constantly-evolving portfolio of innovative product solutions. A consistent customer-focussed approach to development also helps ensure that products are always designed with user needs at the forefront of our minds.

Reflecting the global nature of today’s ophthalmic market, we continue to actively build a network of close links with leading universities and research organisations across the world. These mutually-beneficial relationships are designed to expand our technical knowledge whilst helping to further the development of life-changing cutting-edge ophthalmic technologies.

Rayner’s great history of working with leading ophthalmic surgeons to make their ideas reality (from the first IOL developed for Harold Ridley in 1949, through designs for Choyce, Strampelli, Epstein, Binkhorst, and more recently in collaboration with Professors Apple and Amon) continues today, and we welcome new product concepts from all external sources. If you are a surgeon, academic, inventor or even a patient with a great idea, we would love to hear from you (contact us: [email protected]).

We believe we have implemented a company structure which is perfectly suited to support our focus on innovative, agile and fast-paced development. Combining this with our commitment to reinvest at least 15% of annual turnover in R&D activities will continue to give us a strong competitive edge in the 21st century ophthalmic market.